Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comprehensive review on potential therapeutics interventions for COVID-19
Heerak Chugh, Amardeep Awasthi, Yashi Agarwal, et al.
European Journal of Pharmacology (2020) Vol. 890, pp. 173741-173741
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

COVID-19: Characteristics and Therapeutics
Rameswari Chilamakuri, Saurabh Agarwal
Cells (2021) Vol. 10, Iss. 2, pp. 206-206
Open Access | Times Cited: 258
Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm
Ali A. Rabaan, Shamsah H. Al-Ahmed, Javed Muhammad, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 436-436
Open Access | Times Cited: 214
COVID-19-associated acute respiratory distress syndrome (CARDS): Current knowledge on pathophysiology and ICU treatment – A narrative review
Carmen A. Pfortmueller, Thibaud Spinetti, Richard D. Urman, et al.
Best Practice & Research Clinical Anaesthesiology (2020) Vol. 35, Iss. 3, pp. 351-368
Open Access | Times Cited: 93
Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID‐19—Mechanisms and Therapeutic Targets
Adriana Fodor, Brîndușa Tiperciuc, Cezar Login, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 83
Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses
Ali A. Rabaan, Shamsah H. Al-Ahmed, Mohammed Garout, et al.
Pathogens (2021) Vol. 10, Iss. 5, pp. 565-565
Open Access | Times Cited: 73
Deep learning in target prediction and drug repositioning: Recent advances and challenges
Junlin Yu, Qing-Qing Dai, Guo‐Bo Li
Drug Discovery Today (2021) Vol. 27, Iss. 7, pp. 1796-1814
Open Access | Times Cited: 44
A review on structural, non-structural, and accessory proteins of SARS-CoV-2: Highlighting drug target sites
Md. Jahirul Islam, Nafisa Nawal Islam, Md. Siddik Alom, et al.
Immunobiology (2022) Vol. 228, Iss. 1, pp. 152302-152302
Open Access | Times Cited: 34
A detailed review of the outbreak of COVID-19
Kabita Das, M. Shivapriya Pingali, Biswaranjan Paital, et al.
Frontiers in Bioscience-Landmark (2021) Vol. 26, Iss. 6, pp. 149-149
Open Access | Times Cited: 33
Development of extra-fine particles containing nanosized meloxicam for deep pulmonary delivery: In vitro aerodynamic and cell line measurements
Petra Party, Dávid Kókai, Katalin Burián, et al.
European Journal of Pharmaceutical Sciences (2022) Vol. 176, pp. 106247-106247
Open Access | Times Cited: 21
7-Ketocholesterol: Effects on viral infections and hypothetical contribution in COVID-19
Imen Ghzaiel, Khouloud Sassi, Amira Zarrouk, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2021) Vol. 212, pp. 105939-105939
Open Access | Times Cited: 29
Prophylactic and therapeutic insights into trained immunity: A renewed concept of innate immune memory
Suresh Bindu, Satyabrata Dandapat, Rajendran Manikandan, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 18
COVID19 associated mucormycosis: Is GRP78 a possible link?
Jyotsna Gumashta, Raghvendra Gumashta
Journal of Infection and Public Health (2021) Vol. 14, Iss. 10, pp. 1351-1357
Open Access | Times Cited: 25
Identifying New COVID-19 Receptor Neuropilin-1 in Severe Alzheimer’s Disease Patients Group Brain Using Genome-Wide Association Study Approach
Key‐Hwan Lim, Sumin Yang, Sung-Hyun Kim, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 24
COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon
Hans Carl Hasselbalch, Vibe Skov, Lasse Kjær, et al.
Cytokine & Growth Factor Reviews (2021) Vol. 60, pp. 28-45
Open Access | Times Cited: 22
In Silico and In Vitro Evaluation of the Molecular Mimicry of the SARS-CoV-2 Spike Protein by Common Short Constituent Sequences (cSCSs) in the Human Proteome: Toward Safer Epitope Design for Vaccine Development
Yuya Mizuno, Wataru Nakasone, Morikazu Nakamura, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 539-539
Open Access | Times Cited: 2
Potential value of pharmacological agents acting on toll-like receptor (TLR) 7 and/or TLR8 in COVID-19
Amani E. Khalifa, Asser I. Ghoneim
Current Research in Pharmacology and Drug Discovery (2021) Vol. 2, pp. 100068-100068
Open Access | Times Cited: 19
Computational Analysis Illustrates the Mechanism of Qingfei Paidu Decoction in Blocking the Transition of COVID-19 Patients from Mild to Severe Stage
Wei Chen, Xianhai Li, Xiang Liu, et al.
Current Gene Therapy (2021) Vol. 22, Iss. 3, pp. 277-289
Closed Access | Times Cited: 18
Hydrogen-oxygen therapy alleviates clinical symptoms in twelve patients hospitalized with COVID-19
Peng Luo, Yuanfang Ding, Yuan He, et al.
Medicine (2022) Vol. 101, Iss. 9, pp. e27759-e27759
Open Access | Times Cited: 12
Wave comparisons of clinical characteristics and outcomes of COVID-19 admissions - Exploring the impact of treatment and strain dynamics
Anna Freeman, Alastair Watson, Paul O’Regan, et al.
Journal of Clinical Virology (2021) Vol. 146, pp. 105031-105031
Open Access | Times Cited: 16
Can Probiotics, Particularly Limosilactobacillus fermentum UCO-979C and Lacticaseibacillus rhamnosus UCO-25A, Be Preventive Alternatives against SARS-CoV-2?
Héctor Valdebenito-Navarrete, Victor Fuentes-Barrera, Carlos T. Smith, et al.
Biology (2023) Vol. 12, Iss. 3, pp. 384-384
Open Access | Times Cited: 5
Scientists, presidents, and pandemics—comparing the science–politics nexus during the Zika virus and COVID‐19 outbreaks
Thomas G. Safford, Emily Whitmore, Lawrence C. Hamilton
Social Science Quarterly (2021) Vol. 102, Iss. 6, pp. 2482-2498
Open Access | Times Cited: 12
Nonself Mutations in the Spike Protein Suggest an Increase in the Antigenicity and a Decrease in the Virulence of the Omicron Variant of SARS-CoV-2
Joji M. Otaki, Wataru Nakasone, Morikazu Nakamura
COVID (2022) Vol. 2, Iss. 3, pp. 407-418
Open Access | Times Cited: 8
Are Persons Treated with Antidepressants and/or Antipsychotics Possibly Better Protected against Severe COVID 19?
Udo Bonnet, Georg Juckel, Norbert Scherbaum, et al.
Pharmacopsychiatry (2021) Vol. 54, Iss. 03, pp. 142-143
Closed Access | Times Cited: 7
Impact of Psychiatric and Related Somatic Medications on the Duration and Severity of COVID-19: A Retrospective Explorative Multi-center Study from the German Metropolitan Ruhr-area
Udo Bonnet, Benedikt B. Claus, Martin Schaefer, et al.
Pharmacopsychiatry (2021) Vol. 55, Iss. 01, pp. 30-39
Closed Access | Times Cited: 7
Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients
Andrea Sacconi, Claudia De Vitis, Luisa de Latouliere, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 11
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top